Table 5.
Physical attributes in all subjects.
| CP (n = 36) | PL (n = 33) | |||||
|---|---|---|---|---|---|---|
| BL | 6 w | 12 w | BL | 6 w | 12 w | |
| Body weight, kg | 57.2 ± 8.2 | 57.2 ± 8.4 | 57.0 ± 8.1 | 56.3 ± 7.5 | 56.3 ± 7.3 | 56.3 ± 7.3 |
| BMI, kg/m2 | 23.3 ± 2.3 | 23.3 ± 2.4 | 23.2 ± 2.5 | 23.5 ± 2.8 | 23.5 ± 2.8 | 23.6 ± 2.7 |
| Abdominal circumference, cm | 86.0 ± 7.5 | 85.4 ± 7.0 ** | 86.3 ± 7.1 | 83.3 ± 8.6 | 85.0 ± 8.1 | 84.0 ± 8.3 |
| Percent body fat, % | 35.0 ± 6.5 | 34.0 ± 6.3 | 33.2 ± 6.3 † | 34.9 ± 7.2 | 34.2 ± 8.1 | 34.2 ± 7.3 |
| Visceral fat index | 103.8 ± 31.6 | 102.2 ± 25.4 * | 103.9 ± 24.1 | 98.9 ± 25.2 | 102.7 ± 24.4 | 98.2 ± 24.8 |
| Muscle mass, kg | 14.1 ± 2.6 | 14.2 ± 2.1 | 14.3 ± 2.1 | 14.1 ± 1.9 | 14.3 ± 2.1 | 14.2 ± 2.1 |
| Muscle mass percentage, % | 25.1 ± 2.4 | 25.2 ± 2.3 | 25.4 ± 2.4 | 25.1 ± 2.7 | 25.5 ± 3.0 | 25.3 ± 2.5 |
| Fat free mass, kg | 36.1 ± 8.6 | 33.9 ± 12.9 | 38.0 ± 6.1 | 36.5 ± 5.6 | 34.8 ± 10.3 | 36.9 ± 5.7 |
Abbreviations: CP, capsinoids group; PL, placebo group; BL, baseline; 6 w, 6th week; 12 w, 12th week. Significantly larger change than PL in linear mixed model repeated ANOVA (* p < 0.05; ** p < 0.01); significant difference between CP and PL in ANCOVA (covariate = baseline value) († p < 0.05).